Salivary duct carcinoma incidence has increased rapidly, possibly reflecting improved diagnostic recognition and reclassification, with only modest survival improvement over the past decade.
Abstract
Background
Salivary duct carcinoma (SDC) is a rare and aggressive malignancy with limited population-based data.
Methods
Incidence trends and survival outcomes were analyzed using the Surveillance, Epidemiology, and End Results database.
Results
A total of 955 cases were identified. The age-adjusted incidence rate increased from 0.158 in 2000 to 1.18 in 2022 (average annual percent change, 10.38%; p < 0.001), accelerating after 2012. Increases were more pronounced among females, older patients, regional-stage disease, and tumors > 2 cm. The 5-year disease-specific survival (DSS) and overall survival were 60.6% and 51.2%, respectively. Advanced age, non-parotid site, larger tumor size, lymph node metastasis, advanced stage, and non-surgical management were independent predictors of worse DSS. Patients diagnosed in 2013-2022 showed better DSS compared with those in 2004-2012 (64.7% vs. 52.0%, p = 0.048).
Conclusion
SDC incidence has increased rapidly, possibly reflecting improved diagnostic recognition and reclassification, with only modest survival improvement over the past decade.
INTRODUCTION
The global rise in early-onset colorectal cancer (EORC) contrasts with declining rates in older adults, suggesting emerging environmental and biological influences. Data from non-Western populations, particularly India, remain scarce despite a young demographic and distinct tumor biology.
METHODS
A retro...
A. Saklani, M. Kazi, Prudvi Raj et al.· European Journal of Surgical...· 0 citations
OBJECTIVE
Malignant salivary gland tumors represent a heterogeneous group of neoplasms with variable management. This study evaluated trends in therapeutic approaches to these cancers to inform evidence-based, personalized care and optimize patient outcomes.
STUDY DESIGN
Retrospective cohort study.
SETTING
Populati...
Christopher Stewart, J. Eyring, Braxton M. Felix et al.· Otolaryngology Head & Neck S...· 0 citations
Male gender, older age, and distant tumor stage are significant predictors of higher mortality, while chemotherapy and surgery substantially improve survival in GBC patients, highlighting the necessity for targeted interventions and personalized treatment approaches to enhance survival rates.
Ayrton I. Bangolo, Behzad Amoozgar, B. Alqinai et al.· Journal of Community Hospita...· 0 citations
Background and purpose This study aimed to investigate treatment patterns and survival outcomes in population-based data describing treatment and survival of primary vaginal carcinoma (VC) in a routine clinical setting, stratified by age group and stage. Methods This nationwide, population-based study included women di...
K. Hellman, M. Bjurberg, C. Borgfeldt et al.· Acta oncologica· 0 citations
BACKGROUND
Gallbladder cancer (GBC) is a rare but aggressive malignancy with poor long-term survival after resection. National data describing temporal changes in adjuvant therapy, surgical quality metrics, and facility-level outcomes remain limited.
METHODS
A retrospective cohort study was performed using the Nation...
R. Cardoso, E. Zineldin, Y. Sakr et al.· Journal of Surgical Oncology· 0 citations
The number of surgically treated EORNET cases substantially increased over time, and local excision was the predominant treatment, compatible with increased detection of indolent lesions through greater endoscopic evaluation.
M. Al Khaldi, Zubair Bayat, Noam Kahana et al.· The American surgeon· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.